436099-97-7 Usage
Uses
Used in Pharmaceutical Drug Synthesis:
4-(PIPERIDIN-4-YL)-MORPHOLINE is used as a precursor in the synthesis of pharmaceutical drugs for its ability to form complex molecular structures that can target specific biological pathways.
Used in Medicinal Chemistry:
As a building block in medicinal chemistry, 4-(PIPERIDIN-4-YL)-MORPHOLINE is utilized for its potential to create novel compounds with therapeutic properties, contributing to the development of new drugs.
Used in Corrosion Inhibition:
4-(PIPERIDIN-4-YL)-MORPHOLINE is used as a corrosion inhibitor in various industries, such as oil and gas, to protect metal surfaces from degradation, extending the lifespan of equipment and infrastructure.
Used in Coordination Chemistry:
In coordination chemistry, 4-(PIPERIDIN-4-YL)-MORPHOLINE is employed as a ligand, enabling the formation of stable complexes with metal ions, which can be applied in areas such as catalysis and materials science.
Used in Chemical Biology and Drug Discovery:
4-(PIPERIDIN-4-YL)-MORPHOLINE has demonstrated inhibitory activity against certain enzymes, making it a valuable tool in chemical biology for understanding enzyme function and in drug discovery for the development of enzyme-targeting therapeutics.
Check Digit Verification of cas no
The CAS Registry Mumber 436099-97-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,6,0,9 and 9 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 436099-97:
(8*4)+(7*3)+(6*6)+(5*0)+(4*9)+(3*9)+(2*9)+(1*7)=177
177 % 10 = 7
So 436099-97-7 is a valid CAS Registry Number.
InChI:InChI=1S/C9H18N2O/c1-3-10-4-2-9(1)11-5-7-12-8-6-11/h9-10H,1-8H2
436099-97-7Relevant articles and documents
11-BETA HSD1 INHIBITORS
-
Page/Page column 173, (2008/06/13)
This invention relates to inhibiting 11βHSD1.
Diaminothiazoles
-
Page/Page column 15, (2008/06/13)
Novel diaminothiazoles of formula (I): [image] are discussed. These compounds selectively inhibit the activity of Cdk4 and are thus useful in the treatment or control of cancer, in particular, the treatment or control of solid tumors. This invention also provides pharmaceutical compositions containing such compounds and methods of treating or controlling cancer, most particularly, the treatment or control of breast, lung, colon, and prostate tumors.
